JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woods, G. L.
Right arrow Articles by Murphy, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woods, G. L.
Right arrow Articles by Murphy, T.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, 01 1997, 121-124, Vol 35, No. 1
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Clinical evaluation of difco ESP culture system II for growth and detection of mycobacteria

GL Woods, G Fish, M Plaunt and T Murphy
Department of Pathology, University of Texas Medical Branch, Galveston 77555-0740, USA.

The reliability of the ESP Culture System II (ESP II; Difco Laboratories, Detroit, Mich.), a continuously monitoring mycobacterial culture system, was evaluated by comparing its performance with the BACTEC TB 460 (BACTEC TB) and Middlebrook 7H11/7H11 selective agar systems. A total of 2,283 specimens of all types (70.7% were respiratory specimens) were cultured; 149 (6.5%) yielded mycobacteria. The most common species recovered were Mycobacterium avium complex (MAC, 73 isolates) and Mycobacterium tuberculosis complex (MTBC, 53 isolates). The recovery rates by individual system were 87, 81, and 65% for ESP II, BACTEC TB, and Middlebrook agar, respectively, for all mycobacteria; the recovery rates were 89, 92, and 89%, respectively, for MTBC. For liquid plus solid medium system combinations, recovery rates for all mycobacteria and for MTBC, respectively, were 91 and 94% for ESP II plus Middlebrook agar and 85 and 96% for BACTEC TB plus Middlebrook agar. The difference between the recovery rates of all mycobacteria by ESP II and by BACTEC TB was not significant, whereas for the individual species, the only significant difference was recovery of more isolates of MAC by ESP II. For those isolates recovered in the individual systems, mean times to detection of all mycobacteria, MTBC, and MAC, respectively, were 13.1, 15.5, and 10.9 days for ESP II; 14.4, 16.6, and 12.1 days for BACTEC TB; and 17.8, 18.3, and 18.8 days for Middlebrook agar. ESP II is a reliable, nonradiometric, less labor-intensive alternative to BACTEC TB for growth and detection of mycobacteria, but as with other liquid culture methods, ESP II should be used in combination with a solid medium, not as a stand-alone system.


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 1997 by the American Society for Microbiology. All rights reserved.